Patents Assigned to Schering-Plough Animal Health Corporation
-
Patent number: 8119667Abstract: Novel fenicol compounds having useful properties as antibiotic prodrugs, are provided, together with methods of making and using these new compounds.Type: GrantFiled: December 18, 2006Date of Patent: February 21, 2012Assignee: Schering-Plough Animal Health CorporationInventors: Tomasz W. Glinka, Dale Edward Shuster, Chander Shekher Celly, Robert D. Simmons, Jason Zhang
-
Patent number: 8084445Abstract: Disclosed are novel formulations for the treatment of otic infections in an animal comprising a triazole anti-fungal compound, a quinolone antibiotic and a corticosteroid such as mometasone furoate monohydrate.Type: GrantFiled: August 10, 2005Date of Patent: December 27, 2011Assignee: Schering-Plough Animal Health CorporationInventors: Abu S Huq, Allan J Weingarten, Robert D Simmons
-
Patent number: 7999005Abstract: An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection.Type: GrantFiled: November 25, 2008Date of Patent: August 16, 2011Assignee: Schering-Plough Animal Health CorporationInventors: Chung Shih, Thomas J. Kennedy, Peter James Knight, Daniel S. Robins, Zezhi Jesse Shao
-
Patent number: 7906538Abstract: Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.Type: GrantFiled: October 31, 2007Date of Patent: March 15, 2011Assignee: Schering-Plough Animal Health CorporationInventors: Adam Gerhardt Meyer, Kevin Norman Winzenberg, David G. Sawutz, Andris Juris Liepa
-
Patent number: 7892561Abstract: The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.Type: GrantFiled: August 4, 2009Date of Patent: February 22, 2011Assignee: Schering-Plough Animal Health CorporationInventors: David E. Junker, Mark D. Cochran
-
Publication number: 20100291125Abstract: The present application relates to osteopontin (Eta-1) polypeptides, nucleic acids that encode Eta-1, antibodies that specifically bind to Eta-1, and methods for enhancing an immune response in an animal.Type: ApplicationFiled: June 24, 2010Publication date: November 18, 2010Applicant: Schering-Plough Animal Health CorporationInventors: BARBARA J. WINSLOW, Dalia Kalabat
-
Patent number: 7759349Abstract: Novel imidazo[1,2-b]pyridazine compounds useful for controlling parasites in animals and methods of treatment of parasite infestation in animals using the compounds are disclosed.Type: GrantFiled: December 22, 2004Date of Patent: July 20, 2010Assignee: Schering-Plough Animal Health CorporationInventors: Kevin N. Winzenberg, Craig L. Francis, David G. Sawutz, Ashit Ganguly
-
Publication number: 20100130960Abstract: Please insert the attached Abstract provided herewith on a separate sheet after the claims. The present invention pertains to a method for administering a predetermined amount of a pharmaceutical composition to an animal comprising the steps of taking a cannula suitable for insertion into a nasal cavity of the animal, slidably connecting the cannula to a delivery device which is suitable for holding the pharmaceutical composition, inserting the cannula via a nostril into the nasal cavity such that a peripheral line of the cannula is contiguous with a circumferential line of the nostril, actuating the delivery device to force the said amount of the pharmaceutical composition through the cannula into the nasal cavity, retracting the cannula from the nasal cavity and removing the cannula from the device. The invention also pertains to an apparatus for performing this method, a cannula for use with the apparatus and a kit containing the required components to perform the method.Type: ApplicationFiled: December 4, 2008Publication date: May 27, 2010Applicants: SCHERING-PLOUGH ANIMAL HEALTH CORPORATION, SCHERING-PLOUGH LTD., SCHERING-PLOUGH PTY. LIMITEDInventor: Mark Francis Spire
-
Patent number: 7718772Abstract: The present invention discloses a canine TSLP protein and a nucleic acid that encodes that protein. Peptide fragments of the protein that comprise specific epitopes of the canine TSLP protein are also disclosed. The canine TSLP protein and related peptide fragments may be used as an antigen for immunological assays, as well as for vaccines that induce anti-TSLP antibodies. The present invention further discloses methods of making and using the canine TSLP gene, the canine TSLP protein, and the related peptide fragments.Type: GrantFiled: December 11, 2007Date of Patent: May 18, 2010Assignee: Schering-Plough Animal Health CorporationInventors: Jeanine D. Mattson, Daniel M. Gorman, Rene de Waal Malefyt, Mohamad A. Morsey
-
Patent number: 7585648Abstract: The invention provides new, specific nucleic acids encoding antigenic peptides from the protein GDF8. The invention also provides nucleic acids encoding fusion proteins comprising the new peptides, immunogens and vaccines based on the nucleic acids encoding new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.Type: GrantFiled: April 2, 2008Date of Patent: September 8, 2009Assignee: Schering-Plough Animal Health CorporationInventors: David E. Junker, Mark D. Cochran
-
Publication number: 20090075962Abstract: An improved weight and growth stimulant for domesticated animals such as cattle, pigs and sheep is comprised of an anabolic agent that is subcutaneously administered in the form of a dual release implant formulation. Increased gains are particularly improved when zeranol is administered in an immediate-release and controlled-release formulation which allows for a one-time dosage injection.Type: ApplicationFiled: November 25, 2008Publication date: March 19, 2009Applicants: Schering-Plough Animal Health Corporation, Schering-Plough LTD., Schering-Plough PTY. LimitedInventors: Chung Shih, Thomas J. Kennedy, Peter James Knight, Daniel S. Robins, Zezhi Jesse Shao
-
Patent number: 7462700Abstract: The present invention provides isolated nucleic acid molecules that encode a substantial part of canine RANKL polypeptide, including the extracellular domains of that polypeptide, the polypeptide and fragments thereof. Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity. Also provided are methods of treating an animal to inhibit or treat the loss of bone minerals.Type: GrantFiled: December 10, 2003Date of Patent: December 9, 2008Assignee: Schering-Plough Animal Health CorporationInventors: Jeanine D. Mattson, Terrill McClanahan
-
Patent number: 7432079Abstract: The invention provides a fusion protein comprising a plant virus coat protein and a GDF8 peptide domain, or antigenic fragment of the GDF8 peptide domain. Plant virus vectors expressing the fusion protein and methods of using these vectors are also provided.Type: GrantFiled: December 21, 2005Date of Patent: October 7, 2008Assignee: Schering-Plough Animal Health CorporationInventors: David E. Junker, Mark D. Cochran, Mark L. Smith, Kenneth E. Palmer, Gregory P. Pogue
-
Patent number: 7371726Abstract: The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.Type: GrantFiled: December 21, 2004Date of Patent: May 13, 2008Assignee: Schering-Plough Animal Health CorporationInventors: David E. Junker, Mark D. Cochran
-
Patent number: 7361689Abstract: Novel florfenicol compounds having the chemical structure: or a pharmaceutically-acceptable salt thereof or a solvate thereof, or prodrug thereof, wherein R1 is CHCl2, CHClF, CHF2, CHBrCl, CH3, CH2N3, CH2CN, CH(R2)NH2 or CH X1X2; where R2 is H, CH3 or CH2OH, and X1 and X2 are independently selected halogens; and R3 is CH2Cl, CH2F, CHF2, CHCl2 or CH2OH are disclosed. The compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without limitation, birds, fish, shellfish and mammals.Type: GrantFiled: December 21, 2004Date of Patent: April 22, 2008Assignee: Schering-Plough Animal Health CorporationInventors: Dale E. Shuster, Scott Hecker, Tomasz W. Glinka, Rajeshwar Singh, Zhuoyi Su
-
Patent number: 7314715Abstract: The present invention provides a novel avian herpesvirus (NAHV) vector and recombinant vaccines made therefrom that are useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease. Methods of immunizing an avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease are also provided.Type: GrantFiled: May 11, 2005Date of Patent: January 1, 2008Assignee: Schering-Plough Animal Health CorporationInventors: Mark D. Cochran, Stephanie M. Cook, Martha A. Wild
-
Patent number: 7312248Abstract: Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.Type: GrantFiled: September 21, 2005Date of Patent: December 25, 2007Assignee: Schering-Plough Animal Health CorporationInventors: Adam Gerhard Meyer, Kevin Norman Winzenberg, David G. Sawutz, Andris Juris Liepa
-
Patent number: 7279168Abstract: The present invention involves a recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a protein. The protein which is encoded is selected from the groups consisting of a feline CD28 protein or an immunogenic portion thereof, a feline cD80 protein or an immunogenic portion thereof, a feline CD86 protein or an immunogenic portion thereof, or a feline CTLA-4 protein or an immunogenic portion thereof. The protein is capable of being expressed when the recombinant virus is introduced into an appropiate host. The present invention also involves a recombinant virus further comprising a foreign nucleic acid encoding an immunogen derived from a pathogen. The present invention also comprises recombinant viruses which are capable of enhancing an immune response in a feline.Type: GrantFiled: April 30, 1999Date of Patent: October 9, 2007Assignees: Texas A & M University System, Schering-Plough Animal Health CorporationInventors: Barbara J. Winslow, Mark D. Cochran, Stephen Hash, Insoo Choi, Ellen Collisson
-
Patent number: 7205398Abstract: The present application relates to osteopontin (Eta-1) polypeptides, nucleic acids that encode Eta-1, antibodies that specifically bind to Eta-1, and methods for enhancing an immune response in an animal.Type: GrantFiled: May 22, 2003Date of Patent: April 17, 2007Assignee: Schering-Plough Animal Health CorporationInventors: Barbara J. Winslow, Dalia Kalabat
-
Patent number: 7164361Abstract: An animal is provided with an identifier for uniquely identifying it. The identifier is entered into a microprocessor-controlled programmable device to start a record for the animal and to record and store information pertaining to the animal into the record. After the recording and storing of information, an electronic unit is activated to indicate to an animal handler a next task to be performed related to the animal. The data may be entered by speech commands and voice recognition software, so that the user can avoid coming into close proximity to the animal. Further, the contents of the record can be processed to provide information to those along the chain from the producers to the feedlots, packing plant and wholesalers/retailers that will assist in the production of a better product.Type: GrantFiled: March 31, 2003Date of Patent: January 16, 2007Assignee: Schering-Plough Animal Health CorporationInventor: Steven A. Poliska